AstraZeneca Revenue Hurt by Drop in Covid-19 Drug Sales

AstraZeneca PLC on Thursday reported a rise in profit for the first quarter, but said a decline in sales of its Covid-19 medicines hurt revenue. The Anglo-Swedish pharma giant posted net profit of $1.80 billion for the period, up from $388 million the year prior, and beating analysts’ expectations…

#astrazenecaplc #anglo